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Cytosolic calcium (Ca2) is a focalpoint of many signal transduction
pathways and modulates a diverse array
of cellular activities ranging from fertil-
ization to cell death (1). Cells generate
Ca2 signals through both internal and
external Ca2 sources. In most cell types,
the major internal Ca2 stores are the
endoplasmic reticulumsarcoplasmic re-
ticulum (ERSR). One mechanism for
mobilizing such stores involves the clas-
sical phosphoinositide pathway. Essen-
tially, the binding of many hormones to
specific receptors on the plasma mem-
brane leads to the activation of an en-
zyme (phosphoinositidase C) that catal-
yses the hydrolysis of phospholipids to
produce the intracellular messenger ino-
sitol 1,4,5-trisphosphate (InsP3). Al-
though derived from a lipid, InsP3 is
water soluble and diffuses into the cell
interior where it encounters InsP3
receptors (InsP3Rs) on the ERSR. The
binding of InsP3 changes the conforma-
tion of InsP3Rs such that an integral
channel is opened, thus allowing the
Ca2 stored at high concentrations in the
ERSR to enter the cytoplasm. A critical
feature of InsP3Rs is that their opening is
regulated by the cytosolic Ca2 concen-
tration. This sensitivity to cytosolic Ca2
allows them to act as Ca2-induced Ca2
release (CICR) channels that promote
the rapid amplification of smaller trigger
events (1).
It was thought that the binding of InsP3
was obligatory for channel opening.
However, in an elegant study in this issue
of PNAS, Foskett and colleagues (2)
demonstrate that a protein could sup-
plant the need for InsP3. Using a yeast
two-hybrid screen, those authors demon-
strate a high-affinity interaction between
the NH2-terminal 600 aa of an InsP3R
and a member of a previously cloned
group of proteins called Ca2 binding
proteins (CaBPs; ref. 3). These proteins
belong to a superfamily of proteins that
includes the well-known protein calmod-
ulin, which bind Ca2 by EF-hand motifs.
CaBPs belong to a subfamily of EF-hand-
containing proteins known as neuronal
calcium sensors (NCS) (4). Although
members of this group of proteins show
great structural similarities, they have
very diverse functional properties. The
NCS subfamily consists of small proteins
(molecular mass 20 kDa) that are ex-
clusively expressed in neurons or retinal
photoreceptors. They have a high degree
of sequence similarity to calmodulin, but
differ with respect to the number of
functional Ca2-binding EF hands. The
proposed physiological roles of NCS pro-
teins include modulation of neurotrans-
mitter release and regulation of gene
transcription (4).
The study by Foskett and colleagues (2)
proposes a new function
for the CaBP members
of the NCS family—
regulation of InsP3Rs
and Ca2 release from
intracellular stores.
CaBPs interacted with
InsP3Rs only in the ami-
no-terminal region that was used for bait,
which also contains the domain where
InsP3 itself binds to the channel. Patch-
clamp recording of single InsP3Rs in the
outer nuclear membrane of Xenopus oo-
cytes indicated that CaBPs could activate
the channels in the presence or absence of
InsP3. In fact, CaBP alone gave rise to
substantial opening of the InsP3Rs (Po
0.8 in optimal conditions), with signifi-
cant gating observed at 10 nM CaBP. The
interaction between CaBPs and InsP3Rs
was greatly potentiated by increasing cy-
tosolic Ca2 over its physiological range
(0.1–1 M). This process critically de-
pended on the EF hands, because muta-
tions that inhibited Ca2 binding to these
domains abrogated the ability of CaBP to
bind and activate InsP3Rs.
The picture that emerges is that CaBPs
can act as endogenous high-affinity li-
gands of InsP3Rs, which can activate
Ca2 release without the need for InsP3
production via the phosphoinositide
pathway (see Fig. 1). Because the action
of CaBPs depends on Ca2 binding,
InsP3R signaling would still operate in a
CICR mode; CaBPs can act on InsP3Rs
to potentiate trigger Ca2 signals arising
from other sources, but presumably can-
not initiate Ca2 transients. At least five
different CaBP isoforms with multiple
splice variants exist, and they appear to
have a clear tissue-specific expression
profile (3). Some of the isoforms are
abundantly expressed in the cerebral cor-
tex and hippocampus, suggesting that
CaBPs may be key mediators of Ca2
signaling in the brain.
Although we can presently only spec-
ulate on the functions of CaBPs in neu-
ronal Ca2 signaling, their subcellular
localization suggests some intriguing
possibilities. Cellu-
lar fractionation
and immunohisto-
chemistry of CaBP-
expressing neurons
suggests that these
proteins are present
in synaptic and den-
dritic compartments, where InsP3Rs are
also located. These are strategic loca-
tions where information processing oc-
curs. If CaBPs can participate in Ca2
signals occurring during synaptic signal-
ing they may have an important role in
memory formation. Ca2 signaling with-
in spines underlie changes in synaptic
plasticity such as long-term potentiation
(LTP) and long-term depression (LTD),
which are models for learning and mem-
ory. Ca2 signals underlie synaptic plas-
ticity, and it is well established that
InsP3Rs are involved in some of these
paradigms (5, 6). It has been proposed
that InsP3Rs act as ‘‘coincidence detec-
tors’’ to interpret simultaneous signals
arising from metabotropic receptors
(producing InsP3) and the Ca2 entry
through voltage-operated Ca2 channel
and receptor-operated Ca2 channels
See companion article on page 7711.
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(such as N-methyl-D-aspartate recep-
tors) (7). CaBPs could obviate the need
for metabotropic stimulation during
LTDLTP, thus enabling InsP3Rs to par-
ticipate in information processing in the
absence of metabotropic receptor acti-
vation. The versatility of InsP3Rs would
be enhanced through this responsiveness
to InsP3 or CaBP, thus enabling them to
operate after activation of metabotropic
or ionotropic mechanisms.
Unless signals become amplified by
CICR, buffering and sequestration usually
determines that Ca2 has a very limited
diffusion within the cytosol of most cells.
InsP3 is more freely diffusible, although it is
typically metabolized to the non-Ca2 re-
leasing messengers inositol 1,4-bisphos-
phate (InsP2) and inositol 1,3,4,5-tetrakis-
phosphate (InsP4) within seconds. The
enzyme that catalyses the latter reaction to
produce InsP4, InsP33-kinase, has been pro-
posed to act as a ‘‘firewall’’ within spines to
stop the spread of InsP3 into dendritic shafts
and neighboring spines (8). If Ca2-bound
CaBP can act as a mobile signal, it may
smuggle an activatory signal beyond the
barrier that prevents InsP3 diffusion, to al-
low InsP3R-dependent Ca2 signaling over
significant distances. An analogous situa-
tion occurs with calmodulin, which can dif-
fuse over tens of micrometers within cells to
allow local Ca2 signals to activate gene
transcription (9, 10).
Just how mobile CaBPs are is not fully
resolved. One feature of the NCS family
is that its members contain consensus
sequences for myristoylation (4). This
posttranslational modification results in
Ca2-dependent translocation of these
proteins, although along distinct routes
(11). Expression of isoform variants of a
CaBP in Chinese hamster ovary cells
revealed that it could have distinct cel-
lular localizations—a short form was
found at or near the plasma membrane,
whereas a longer homologue was associ-
ated with the cytoskeleton (3). The abil-
ity of CaBPs to bind and activate InsP3Rs
would clearly be altered if they were
tethered by lipid groups or structural
proteins distant from InsP3Rs.
Although the study from Foskett and
colleagues (2) clearly demonstrates that
CaBPs can regulate the activation of
InsP3Rs, there are clearly many outstand-
ing questions concerning their mode of
action. InsP3 can have complicated effects
on InsP3Rs; it has been demonstrated to
cause intrinsic inactivation of InsP3Rs and
at high concentrations to protect them
from Ca2-dependent inhibition (12). It
will be interesting to see whether CaBPs
can replicate all of the effects of InsP3 on
channel gating. Furthermore, it is possible
that activation of InsP3Rs is not the sole
function of CaBPs. In common with other
members of the NCS subfamily, they ap-
pear to interact with several targets (4).
CaBPs have been demonstrated to acti-
vate calmodulin-dependent kinase II and
G protein-coupled receptor kinases in
vitro (3). Whether such interactions occur
in vivo is not yet known, however, it points
to a potential pleiotropic action of the
CaBPs after a Ca2 signal. In addition, the
CaBPs have consensus sequences for
phosphorylation and have been shown to
be phosphorylated in hippocampal slices
in situ (13). Their functions could there-
fore be modulated by upstream kinases.
Another possibility is that the expression
of CaBPs could be modulated in a devel-
opmental- or activity-dependent manner,
in which case their effects on the InsP3Rs
could vary substantially.
For the activation of calmodulin-
dependent kinase II and G protein-
coupled receptor kinases, CaBPs essen-
tially mimicked the role of calmodulin (3).
Interestingly, InsP3Rs also have calmodu-
lin binding regions, which can modulate
the activity of the channels (14–16). One
of the calmodulin binding sites has been
mapped to the NH2-terminal 159 aa of
the InsP3R (17), which is within the
‘‘bait’’ region used by Yang et al. (2) in
their yeast two-hybrid screen. However,
in their study, calmodulin had little effect
on the interaction of CaBPs with
InsP3Rs, suggesting that they have dis-
tinct binding sites. In addition, calmod-
ulin did not activate InsP3R channel ac-
tivity in membrane patches. Therefore,
the effects of CaBP and calmodulin on
InsP3Rs appear to occur through distinct
binding sites. It is plausible that these
two proteins may have opposite effects
on the opening of InsP3Rs, with CaBPs
causing Ca2-dependent activation and
calmodulin evoking Ca2-dependent in-
hibition.
CaBPs are not the only members of
the NCS family that regulate intracell-
ular Ca2 signals. Neuronal Ca2 sensor
1frequenin has been shown to activate
phosphatidylinositol 4-kinase (18) and
facilitate the activation of PQ-type
voltage-operated Ca2 channels (19).
Therefore, several of the NCS proteins
have the capacity to both interpret and
modulate neuronal Ca2 signals.
The demonstration that CaBPs can
activate InsP3Rs in the absence of InsP3
raises many important questions for fu-
ture work. CaBPs essentially endow
InsP3Rs with the ability to display CICR
without InsP3 binding. This would make
them functionally equivalent to ryando-
dine receptors (RyRs), which are intra-
cellular Ca2 release channels directly
gated by Ca2. Neurons expressing
CaBPs, InsP3Rs, and RyRs would there-
fore possess two channels capable of
autonomous CICR and potentially caus-
ing steeply regenerative Ca2 signals. It
will be important to find out what decel-
erates CaBP-induced Ca2 release to
prevent it from simply running away with
itself. Additional questions include the
localization and translocation of CaBPs.
Does this limit or enhance their effects
on InsP3Rs? The observation that CaBPs
can bind to InsP3Rs at low Ca2 concen-
tration (2) suggests that the Ca2-free
forms of these proteins can be prebound
to InsP3Rs. This may be a way of speed-
ing up the responsiveness of InsP3Rs, in
a similar way that complexing apo-cal-
modulin does for PQ-type voltage-
Fig. 1. Dual pathways for activation of InsP3Rs. Shown are the alternative pathways leading to InsP3R
activation in neurons expressing CaBPs. Metabotropic receptors lead to InsP3 production via phospholipase C,
whereas ionotropic stimulation produces an influx of Ca2 that engages CaBP-bound InsP3Rs or recruits CaBP
to the InsP3R. Both metabotropic and ionotropic pathways lead to the activation of InsP3Rs. InsP3 requires the
concurrent binding of Ca2 to an activatory site on the InsP3R. It is presently unclear whether the Ca2-bound
form CaBP is sufficient for InsP3R opening, or if Ca2 is also required to bind to InsP3Rs independently.
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operated Ca2 channels (20). Finally, are
InsP3Rs engaged with CaBP still respon-
sive to InsP3, or do CaBPs completely
decouple the phosphoinositide signaling
pathway from Ca2 release? Clearly, the
novel function for CaBPs proposed by
Foskett and colleagues (2) opens up a
new concept in the regulation of Ca2
release.
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